Related Experiment Video
Updated: May 9, 2026

qKAT: Quantitative Semi-automated Typing of Killer-cell Immunoglobulin-like Receptor Genes
Published on: March 6, 2019
HLA class III genes involvement in Kawasaki disease: a case-control study in Caucasian population
Elisa Maggioli1, Chiara Boiocchi, Michele Zorzetto
1Laboratory of Immunogenetics, Department of Biology & Biotechnology "L.Spallanzani", University of Pavia, Pavia, Italy.
Insights
Genetic analysis of Kawasaki disease (KD) reveals significant variations in specific gene polymorphisms, particularly within the Tumor Necrosis Factor (TNF) and Heat Shock Protein (HSPA) genes. These findings suggest a potential genetic link to KD susceptibility.
Area of Science:
- Immunogenetics
- Pediatric Rheumatology
- Molecular Biology
Background:
- Kawasaki disease (KD) is an acute febrile vasculitis affecting young children, with unknown etiological factors.
- Clinical variability in KD has hindered the identification of causative agents.
- Emerging evidence highlights the roles of genetics and immune system dysregulation in KD pathogenesis.
Purpose of the Study:
- To investigate the association between functional polymorphisms in Human Leukocyte Antigen (HLA) class III genes and Kawasaki disease susceptibility.
- To analyze genetic variations in AGER, TNF, HSPA1A, HSPA1B, and HSPA1L genes in Caucasian KD patients and healthy controls.
Main Methods:
- Genomic DNA was analyzed from 74 Caucasian KD cases and 440 healthy controls.
- Functional polymorphisms in AGER, TNF, HSPA1A, HSPA1B, and HSPA1L genes were characterized.
- Allele, genotype, and haplotype frequencies were compared using chi-squared and Fisher's exact tests.
Main Results:
- Significant deviations were observed in TNF (-308 and -238) and HSPA1A (+190), HSPA1L (+2437) polymorphism genotype and allele frequencies between KD patients and controls.
- A statistically significant decrease in the CG haplotype for TNF -238 and HSPA1L was noted in KD patients.
- Specific genotypes (TNF -308 GG, TNF -238 AA, HSPA1A +190 GC, HSPA1L +2437 TT/TC) and alleles (HSPA1L T/C) showed significant associations with KD.
Conclusions:
- The study suggests a potential involvement of the HLA class III region in Kawasaki disease susceptibility.
- Specific genetic polymorphisms in TNF and HSPA genes may influence KD risk.
- The decreased frequency of the TNF -238/HSPA1L CG haplotype may confer protection against KD-related inflammation.
Abstract:
Kawasaki disease (KD) is an acute, multisystemic, febrile vasculitis of unknown aetiology, which affects young children mainly under 5 years of age. The clinical variability has until now prevented to decrypt KD aetiological factors. Recently, the importance of genetics and the pivotal role of the immune system have emerged. To investigate in this direction, genomic DNA from 74 Caucasian KD cases and 440 healthy controls has been analysed to characterize functional polymorphisms of relevant HLA class III genes: AGER -429 and -374, TNF -857, -308 and -238, HSPA1A +190, HSPA1B +1267 and HSPA1L +2437. Allele, genotype and haplotype frequencies were therefore compared with the chi-squared test and Fisher's exact test. Our data showed significant deviations between patients with Kawasaki disease and controls concerning the TNF -308 polymorphism genotype (GG: P = 0.0449) and allele (G,A: P = 0.0433) and -238 polymorphism genotype frequencies (AA: P = 0.0351). Moreover, we found differences concerning the HSPA1A +190 polymorphism (GC: P = 0.0317) and the HSPA1L +2437 polymorphism (TT: P = 0.0072; TC: P = 0.0250; T: P = 0.0037; C: P = 0.0037). The calculation of TNF -238 and HSPA1L haplotype frequencies also pointed out a statistically significant decrease in patients of CG haplotype (P = 0.0001), which could have a role in protecting from the inflammatory processes that characterize the disease progression. The results obtained point to a possible involvement of the entire HLA class III region in KD susceptibility.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Inflammatory Bowel Disease III: Crohn's Disease
Graves' Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Incomplete Dominance
